Doctors in the Ivermectin Interest Group have welcomed the University of the Free State s decision to conduct a clinical trial protocol to determine the efficacy of ivermectin for the treatment of Covid-19. File Picture: Moeletsi Mabe/African News Agency(ANA)
Clinical trial on efficacy of Ivermectin welcomed
By Lyse Comins
Share
Durban - Doctors in the Ivermectin Interest Group (IIG) have welcomed the University of the Free State s (UFS) decision to conduct a clinical trial protocol to determine the efficacy of ivermectin for the treatment of Covid-19.
But the group have cautioned that in many countries double blind placebo controlled trials would be considered unethical because of the considerable number of people that would die unnecessarily to confirm what was “most likely to become a known fact .